申请人:MERCK PATENT GMBH
公开号:WO2014206524A1
公开(公告)日:2014-12-31
Compounds of the formula (I), in which R1, X and n have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
式(I)中的化合物,其中R1、X和n具有权利要求1中指示的含义,是坦克酶的抑制剂,可用于治疗癌症、心血管疾病、中枢神经系统损伤和不同形式的炎症等疾病。